Sessions

Workforce of the Future: Talent, Change Management and Enabling Future Development
Delivering Projects and Managing Timelines in the Variable, Continuously Changing Environment Of Cell and Gene Therapy
How to Market my Biotech to Investors: Lessons Learned from Successful Investment and Funding Rounds
Patient and Payer Challenges: Enabling Access to Patients through Market Access, Pricing and Patient-Led Discussion
Moving the Industry Towards Automated Systems for Scale-up Success
Tech Review: New Platforms and Closed-Systems to Enable Commercial Success
Working With a CDMO is not Just an Outsourcing Contract but a Partnership: Learnings from Successful Biotech/CDMO Partnerships
Overcoming Challenges and Setting Up for Success on the Path to Commercialisation
Overcoming Challenges and Setting Up for Success on the Path to Commercialisation

Workforce of the Future: Talent, Change Management and Enabling Future Development

26 Jan 2022
13:30
SPONSORED BY
Heidrick & Struggles
Cell and Gene Therapy Catapult
TITLE21 Health Solutions

13:30 Chairperson’s Opening
Jeff Boyd, Partner and Life Sciences Tools & Services Sector Co-Leader, Heidrick & Struggles

13:35 Scaling Your Culture

  • Finding your force multipliers
  • Anchoring your culture
  • Nurturing belonging and driving results

Angela Justice, Chief People Officer, TCR2 Therapeutics

13:50 Skills and Talent Collaboration to Accelerate Industry Growth

  • Sector collaboration to define the challenge and collaborate to turn it to an advantage
  • Coordinated networks to deliver immediate skills impact
  • Utility of reality platforms to accelerate success
  • Generating a blended talent pipeline to ensure a sustainable sector

Sharon Brownlow, Chief Business Officer, Cell and Gene Therapy Catapult

14:05 Building A Commercial Talent Engine for Cell & Gene 

  • New therapy modalities require new skill sets
  • Defining and building competencies
  • Attracting and retaining talent in a highly competitive space
  • Small Biotech vs Big Pharma  considerations

Jill Elliott, Vice President, Cell Therapy Commercialization, Novo Nordisk

14:20 How Digital Transformation is a Prerequisite for the Future Workforce

  • Digital technology’s critical role in developing and supporting the future workforce
  • Enabling talent to thrive in an ever-changing environment
  • Improve workforce and customer satisfaction through quality and sustainability measures

Lynn Fischer, Chief Executive Officer, Title 21 Health Solutions

14:35 Speaker Q&A and Panel Discussion

Speakers

Jeff Boyd
Partner and Life Sciences Tools & Services Sector Co-Leader
Heidrick & Struggles
Angela Justice
Chief People Officer
TCR2 Therapeutics
Jill Elliott
Vice President, Cell Therapy Commercialisation
Lynn Fischer
Chief Executive Officer
TITLE21 Health Solutions
Sharon Brownlow
Chief Business Officer
Cell and Gene Therapy Catapult